Spruce Biosciences names Jessica Cohen Pfeffer vice president, clinical development - SPRB News | RalliesSpruce Biosciences names Jessica Cohen Pfeffer vice president, clinical development
S
SPRB• Spruce Biosciences appoints vice president, clinical development
- Spruce Biosciences appointed Jessica Cohen Pfeffer as vice president, clinical development, effective today.
- She previously spent over a decade at BioMarin, most recently as executive medical director leading clinical sciences for Brineura.
- Pfeffer supported key regulatory milestones for enzyme replacement therapies, including approvals in the U.S., Europe, and the U.K.
- Spruce is advancing a planned BLA submission for tralesinidase alfa enzyme replacement therapy in Sanfilippo Syndrome Type B.
•